Schurgers Leon J, Vermeer Cees
Department of Biochemistry and Cardiovascular Research Institute, Maastricht University, P.O. Box 616, 6200 MD, Maastricht, The Netherlands.
Biochim Biophys Acta. 2002 Feb 15;1570(1):27-32. doi: 10.1016/s0304-4165(02)00147-2.
Vitamin K is a group name for K1 (phylloquinone) and K2 (menaquinones). Both forms contribute to the tissue vitamin K status. Following intestinal absorption, the serum transport of these lipophilic compounds to their target tissues takes place via lipoproteins. In previous studies we have found that K1 is preferentially accumulated in the liver, whereas menaquinones have a more widespread distribution pattern. Here we have tested whether these differences may be explained by the different liposolubility of the various K-vitamers, resulting in their association with different lipoprotein particles. Six healthy male volunteers received a mixture containing 2 micromol of each of three K vitamers (K1, MK-4, and MK-9) dissolved in corn oil. Blood was obtained at baseline and at different time intervals after intake for the measurement of vitamin K in serum and in the lipoprotein fractions. During the first 4 h after intake all K-vitamins were found to be associated predominantly with the triacylglycerol-rich lipoprotein (TGRLP) fraction. Since the TGRLP fraction is mainly cleared by the liver, this suggests that initially most of the K-vitamins are transported to the liver. In contrast to K1, however, both menaquinones investigated were also found in TGRLP and low-density lipoprotein, whereas MK-4 was even present in high-density lipoprotein. This explains why menaquinones may have a different distribution profile and suggests a relatively large impact of menaquinones on extra-hepatic vitamin K status than generally assumed. Moreover, the very long half-life time of MK-9 in the circulation indicates that it may form a more constant source of vitamin K than are either K1 or MK-4.
维生素K是K1(叶绿醌)和K2(甲萘醌)的统称。这两种形式都对组织中的维生素K状态有贡献。在肠道吸收后,这些亲脂性化合物通过脂蛋白进行血清转运至其靶组织。在先前的研究中,我们发现K1优先在肝脏中积累,而甲萘醌具有更广泛的分布模式。在这里,我们测试了这些差异是否可以由各种维生素K异构体不同的脂溶性来解释,这导致它们与不同的脂蛋白颗粒相关联。六名健康男性志愿者接受了一种混合物,其中包含三种维生素K异构体(K1、MK-4和MK-9)各2微摩尔,溶解于玉米油中。在基线以及摄入后不同时间间隔采集血液,用于测定血清和脂蛋白组分中的维生素K。在摄入后的最初4小时内,发现所有维生素K主要与富含三酰甘油的脂蛋白(TGRLP)组分相关联。由于TGRLP组分主要由肝脏清除,这表明最初大多数维生素K被转运至肝脏。然而,与K1不同,所研究的两种甲萘醌也存在于TGRLP和低密度脂蛋白中,而MK-4甚至存在于高密度脂蛋白中。这解释了为什么甲萘醌可能具有不同的分布概况,并表明甲萘醌对肝外维生素K状态的影响比一般认为的要大。此外,MK-9在循环中的半衰期非常长,这表明它可能比K1或MK-4形成更稳定的维生素K来源。